[ad_1]
An anti-mosquito drug for human blood has reduced the number of malaria cases in children by 20%, which could help fight deadly malaria, according to the 20 Minot French website.
A new study found that the ivermectin-based drug – administered to people living in risky areas – would kill the insects that sting them.
The study, published March 13 in The Lancet, says the treatment would be particularly deadly for mosquitoes responsible for spreading malaria, according to the site.
US researchers tested the new 18-week method in 2,700 people, including 590 children in Burkina Faso, noting that it had no side effects of ivermectin and that people treated had less malaria.
The effects were more pronounced among the children treated, all the more so as they were twice as numerous as those who had not reported the disease. Experts now have to perform new tests on a larger scale, according to the site.
"This study is the first to have an impact on society and to show a new path for the fight against malaria," says specialist Chris Draculi of The Independent.
The researchers believe that the combination of ivermectin with other anti-inflammatory drugs can help stop the development of malaria and hope to eradicate this disease, which kills half a million people every year worldwide. .
[ad_2]
Source link
